Visual and anatomic outcomes of cataract surgery with intraoperative or postoperative complications in a teaching institution

Ninel Gregori, Marianeli Rodriguez, Patrick C. Staropoli, Sapir Z. Karli, Anat Galor, Sarah Wellik, Raquel Goldhardt, Wei Shi, Anna Junk

Research output: Contribution to journalArticle

Abstract

Objective: To review visual and anatomic outcomes after cataract surgery with complications in a teaching institution. Methods: Consecutive case series. A chart review was conducted of patients who underwent phacoemulsification with intraoperative or postoperative complications, performed by ophthalmology residents under direct supervision of experienced ophthalmology attending physicians. Best corrected visual acuity (BCVA), OCT parameters, and postoperative treatments were reviewed at 1, 3, 6, and 12 months postoperatively. Results: One hundred thirty-three eyes were analyzed. Mean BCVA was 50 ± 23 approximate Early Treatment Diabetic Retinopathy Study letters at the preoperative visit and improved by a mean of 8 letters (n = 128; p = 0.001), 16 letters (n = 117; p < 0.001), 14 letters (n = 79; p < 0.001), and 4 letters (n = 34; p = 0.37) at 1, 3, 6, and 12 months. The mean OCT central subfoveal thickness increased by less than 50 μm at all time points and this change was not statistically significant at 12 months. BCVA increased by 3 lines in 41%, 56%, 57%, and 44% of eyes at 1, 3, 6, and 12 months. Median BCVA was 20/40 or better at each follow-up period. Fifty-three (40%) eyes required a secondary surgical procedure due to intraoperative or postoperative complication. A significant proportion of eyes received anti-inflammatory drops through 1 year. Conclusions: After cataract surgery with intraoperative or postoperative complications, a majority of eyes experienced substantial visual gains and only mild retinal thickening while being managed with long-term anti-inflammatory drops and additional surgical procedures.

Original languageEnglish (US)
JournalCanadian Journal of Ophthalmology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Intraoperative Complications
Cataract
Teaching
Visual Acuity
Ophthalmology
Anti-Inflammatory Agents
Phacoemulsification
Diabetic Retinopathy
Physicians
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

@article{e21e875f0aca4cd397ac0c54b5e07ae9,
title = "Visual and anatomic outcomes of cataract surgery with intraoperative or postoperative complications in a teaching institution",
abstract = "Objective: To review visual and anatomic outcomes after cataract surgery with complications in a teaching institution. Methods: Consecutive case series. A chart review was conducted of patients who underwent phacoemulsification with intraoperative or postoperative complications, performed by ophthalmology residents under direct supervision of experienced ophthalmology attending physicians. Best corrected visual acuity (BCVA), OCT parameters, and postoperative treatments were reviewed at 1, 3, 6, and 12 months postoperatively. Results: One hundred thirty-three eyes were analyzed. Mean BCVA was 50 ± 23 approximate Early Treatment Diabetic Retinopathy Study letters at the preoperative visit and improved by a mean of 8 letters (n = 128; p = 0.001), 16 letters (n = 117; p < 0.001), 14 letters (n = 79; p < 0.001), and 4 letters (n = 34; p = 0.37) at 1, 3, 6, and 12 months. The mean OCT central subfoveal thickness increased by less than 50 μm at all time points and this change was not statistically significant at 12 months. BCVA increased by 3 lines in 41{\%}, 56{\%}, 57{\%}, and 44{\%} of eyes at 1, 3, 6, and 12 months. Median BCVA was 20/40 or better at each follow-up period. Fifty-three (40{\%}) eyes required a secondary surgical procedure due to intraoperative or postoperative complication. A significant proportion of eyes received anti-inflammatory drops through 1 year. Conclusions: After cataract surgery with intraoperative or postoperative complications, a majority of eyes experienced substantial visual gains and only mild retinal thickening while being managed with long-term anti-inflammatory drops and additional surgical procedures.",
author = "Ninel Gregori and Marianeli Rodriguez and Staropoli, {Patrick C.} and Karli, {Sapir Z.} and Anat Galor and Sarah Wellik and Raquel Goldhardt and Wei Shi and Anna Junk",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jcjo.2018.05.015",
language = "English (US)",
journal = "Canadian Journal of Ophthalmology",
issn = "0008-4182",
publisher = "Canadian Ophthalmological Society",

}

TY - JOUR

T1 - Visual and anatomic outcomes of cataract surgery with intraoperative or postoperative complications in a teaching institution

AU - Gregori, Ninel

AU - Rodriguez, Marianeli

AU - Staropoli, Patrick C.

AU - Karli, Sapir Z.

AU - Galor, Anat

AU - Wellik, Sarah

AU - Goldhardt, Raquel

AU - Shi, Wei

AU - Junk, Anna

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: To review visual and anatomic outcomes after cataract surgery with complications in a teaching institution. Methods: Consecutive case series. A chart review was conducted of patients who underwent phacoemulsification with intraoperative or postoperative complications, performed by ophthalmology residents under direct supervision of experienced ophthalmology attending physicians. Best corrected visual acuity (BCVA), OCT parameters, and postoperative treatments were reviewed at 1, 3, 6, and 12 months postoperatively. Results: One hundred thirty-three eyes were analyzed. Mean BCVA was 50 ± 23 approximate Early Treatment Diabetic Retinopathy Study letters at the preoperative visit and improved by a mean of 8 letters (n = 128; p = 0.001), 16 letters (n = 117; p < 0.001), 14 letters (n = 79; p < 0.001), and 4 letters (n = 34; p = 0.37) at 1, 3, 6, and 12 months. The mean OCT central subfoveal thickness increased by less than 50 μm at all time points and this change was not statistically significant at 12 months. BCVA increased by 3 lines in 41%, 56%, 57%, and 44% of eyes at 1, 3, 6, and 12 months. Median BCVA was 20/40 or better at each follow-up period. Fifty-three (40%) eyes required a secondary surgical procedure due to intraoperative or postoperative complication. A significant proportion of eyes received anti-inflammatory drops through 1 year. Conclusions: After cataract surgery with intraoperative or postoperative complications, a majority of eyes experienced substantial visual gains and only mild retinal thickening while being managed with long-term anti-inflammatory drops and additional surgical procedures.

AB - Objective: To review visual and anatomic outcomes after cataract surgery with complications in a teaching institution. Methods: Consecutive case series. A chart review was conducted of patients who underwent phacoemulsification with intraoperative or postoperative complications, performed by ophthalmology residents under direct supervision of experienced ophthalmology attending physicians. Best corrected visual acuity (BCVA), OCT parameters, and postoperative treatments were reviewed at 1, 3, 6, and 12 months postoperatively. Results: One hundred thirty-three eyes were analyzed. Mean BCVA was 50 ± 23 approximate Early Treatment Diabetic Retinopathy Study letters at the preoperative visit and improved by a mean of 8 letters (n = 128; p = 0.001), 16 letters (n = 117; p < 0.001), 14 letters (n = 79; p < 0.001), and 4 letters (n = 34; p = 0.37) at 1, 3, 6, and 12 months. The mean OCT central subfoveal thickness increased by less than 50 μm at all time points and this change was not statistically significant at 12 months. BCVA increased by 3 lines in 41%, 56%, 57%, and 44% of eyes at 1, 3, 6, and 12 months. Median BCVA was 20/40 or better at each follow-up period. Fifty-three (40%) eyes required a secondary surgical procedure due to intraoperative or postoperative complication. A significant proportion of eyes received anti-inflammatory drops through 1 year. Conclusions: After cataract surgery with intraoperative or postoperative complications, a majority of eyes experienced substantial visual gains and only mild retinal thickening while being managed with long-term anti-inflammatory drops and additional surgical procedures.

UR - http://www.scopus.com/inward/record.url?scp=85052137555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052137555&partnerID=8YFLogxK

U2 - 10.1016/j.jcjo.2018.05.015

DO - 10.1016/j.jcjo.2018.05.015

M3 - Article

C2 - 31109480

AN - SCOPUS:85052137555

JO - Canadian Journal of Ophthalmology

JF - Canadian Journal of Ophthalmology

SN - 0008-4182

ER -